- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03244514
Biomarker-guided Implementation of the AKI Bundle (PrevAKI-mc)
Biomarker-guided Implementation of the Cardiovascular (CV) Surgery AKI Bundle to Reduce the Occurrence of AKI After Cardiac Surgery- Prevention of AKI
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury.
The investigators hypothesize that the implementation of a bundle of supportive measures adapted to patients undergoing cardiovascular surgery reduces the occurence of AKI.
A Randomized prospective multicenter trial is needed to investigate whether the implementation of the bundle of measures is effective to prevent AKI in high risk patients undergoing cardiac surgery. In this feasibility trial the investigators will analyze the compliance rate to the trial protocol in a multicenter, multinational cohort in preparation for a large randomized controlled trial.
연구 개요
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Bochum, 독일, D-44789
- Universitätsklinikum Bergmannsheil Bochum
-
Gießen, 독일, 35392
- Universitätsklinikum Gießen, Klinik für Herz-, Kinderherz- und Gefäßchirurgie
-
Marburg, 독일, D-35033
- Philipps-Universitat Marburg
-
Muenster, 독일, D-48149
- University Hospital Muenster
-
-
-
-
-
Brussels, 벨기에, 1020
- CHU Brugmann, Intensive Care Medicine
-
Gent, 벨기에, 9000
- Universitair Ziekenhuis Gent
-
Gent, 벨기에, 9000
- AZ Maria Middelares
-
-
-
-
-
Barcelona, 스페인, 08041
- Hospital del la Santa Creu i Sant Pau; Unidad de Cuidados Intensivos
-
-
-
-
-
London, 영국, SE5 9RS
- King's College Hospital
-
London, 영국, SE1 7EH
- St. Thomas' Hospital
-
-
-
-
-
Milan, 이탈리아, 20132
- Ospedale San Raffaele S.r.I., I.R.C.C.S.
-
Milano, 이탈리아, I-20138
- Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientific
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB)
- Urinary [TIMP-2] * [IGFBP7] >= 0.3 4h after CPB
- Written informed consent
Exclusion Criteria:
- Preexisting AKI (stage 1 and higher)
- Patients with cardiac assist devices (ECMO, LVAD, RVAD, IABP)
- Pregnancy, breastfeeding
- Known (Glomerulo-)-Nephritis, intersstitial nephritis or vasculitis
- CKD with eGFR < 20 mL/min
- Dialyses dependent CKD
- Prior kidney transplant within the last 12 months
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Intervention group
Implementation of the cardiovascular surgery AKI bundle
|
Implementation of the cardiovascular AKI bundle (see arm description)
|
간섭 없음: Control group
The patients will receive standard of care (according to each center)
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Compliance rate
기간: 48 hours after start of intervention
|
proportion of patients who are treated according to the trial protocol: CV surgery AKI bundle fulfilled at all time
|
48 hours after start of intervention
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
인류
기간: 중재 시작 후 90일
|
중재 시작 후 90일
|
|
Occurence of AKI
기간: 72 hours after start of intervention
|
72 hours after start of intervention
|
|
Moderate and severe AKI
기간: 72 hours after start of intervention
|
72 hours after start of intervention
|
|
Free-days through of vasoactive medications and mechanical ventilation
기간: 28 days after start of intervention
|
28 days after start of intervention
|
|
Renal recovery
기간: 90 days after start of intervention
|
renal recovery is defined as serum creatinine levels < 0.5 mg/dl higher than baseline serum creatinine (creatinine level before surgery)
|
90 days after start of intervention
|
ICU and hospital stay
기간: up to 1 year after start of intervention (until discharge)
|
up to 1 year after start of intervention (until discharge)
|
|
Number of patients with renal replacement therapy
기간: 90 days after start of intervention
|
90 days after start of intervention
|
공동 작업자 및 조사자
수사관
- 연구 의자: Zarbock, PhD, University Hospital Muenster, Dept. of Anesthesiology
간행물 및 유용한 링크
일반 간행물
- Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017 Nov;43(11):1551-1561. doi: 10.1007/s00134-016-4670-3. Epub 2017 Jan 21. Erratum In: Intensive Care Med. 2017 Mar 7;:
- Zarbock A, Kullmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, Rajani R, McCorkell S, Arndt C, Wulf H, Irqsusi M, Monaco F, Di Prima AL, Garcia Alvarez M, Italiano S, Miralles Bagan J, Kunst G, Nair S, L'Acqua C, Hoste E, Vandenberghe W, Honore PM, Kellum JA, Forni LG, Grieshaber P, Massoth C, Weiss R, Gerss J, Wempe C, Meersch M. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg. 2021 Aug 1;133(2):292-302. doi: 10.1213/ANE.0000000000005458.
- Kullmar M, Massoth C, Ostermann M, Campos S, Grau Novellas N, Thomson G, Haffner M, Arndt C, Wulf H, Irqsusi M, Monaco F, Di Prima A, Garcia Alvarez M, Italiano S, Cegarra SanMartin V, Kunst G, Nair S, L'Acqua C, Hoste EAJ, Vandenberghe W, Honore PM, Kellum J, Forni L, Grieshaber P, Weiss R, Gerss J, Wempe C, Meersch M, Zarbock A. Biomarker-guided implementation of the KDIGO guidelines to reduce the occurrence of acute kidney injury in patients after cardiac surgery (PrevAKI-multicentre): protocol for a multicentre, observational study followed by randomised controlled feasibility trial. BMJ Open. 2020 Apr 6;10(4):e034201. doi: 10.1136/bmjopen-2019-034201.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Intervention에 대한 임상 시험
-
VA Office of Research and Development모집하지 않고 적극적으로
-
Washington University School of MedicineSt. Jude Children's Research Hospital완전한
-
University of MichiganNational Institute on Drug Abuse (NIDA)모병
-
University of MichiganNational Institute of Nursing Research (NINR)완전한
-
RTI InternationalUniversity of North Carolina, Chapel Hill초대로 등록결절성 경화증 | 다운 증후군 | 뒤시엔 근이영양증 | 프래더-윌리 증후군 | 취약 X 증후군 | 레트 증후군 | 터너 증후군 | 윌리엄스 증후군 | 엔젤만 증후군 | 염색체 22q11.2 결실 증후군 | 클라인펠터 증후군 | 펠란-맥더미드 증후군 | Dup15Q 증후군 | 스미스 마제니스 증후군미국
-
University of MichiganNational Center for Advancing Translational Sciences (NCATS)완전한